Close Menu
  • Home
  • Vaccines
  • Politics
  • Health
  • Tech
  • Sports
  • Research
  • Fitness
  • Careers
What's Hot

Health Canada approves Novartis’ KISQALI® for HR+/HER2- early breast cancer patients at high risk of recurrence

Sheriff, county lawyer seeking mental health funds at Minnesota State Capitol

Chronic absences have not disappeared. Research shows that poor children are most hurt.

Facebook X (Twitter) Instagram
subjectional.com
Subscribe
  • Home
  • Vaccines
  • Politics
  • Health
  • Tech
  • Sports
  • Research
  • Fitness
  • Careers
subjectional.com
Home » Daxtra selected as Nucleus Research’s 2024 Accelerator of the Year
Research

Daxtra selected as Nucleus Research’s 2024 Accelerator of the Year

Paul E.By Paul E.October 28, 2024No Comments2 Mins Read
Share Facebook Twitter Pinterest Copy Link Telegram LinkedIn Tumblr Email
Share
Facebook Twitter LinkedIn Pinterest Email


RICHMOND, Va., Oct. 28, 2024 (GLOBE NEWSWIRE) — Daxtra, a leading provider of AI-powered software for the talent acquisition ecosystem, has been named an “Accelerator” in Nucleus Research’s 2024 Standalone Talent Acquisition Technology Value Matrix. ” was recognized. . This report focused on the best solutions to support the recruiting process, evaluating standalone talent acquisition technology providers based on product functionality, ease of use, and value to customers. Daxtra is one of the few providers considered to accelerate hiring with cutting-edge technology that leverages AI to help recruiters quickly identify top talent and reallocate time to strategic initiatives. is.

Report author Evelyn McMullen, research manager at Nucleus Research, also cited several trends impacting the hiring landscape, including the continued adoption of machine learning and generative AI. Despite the unpredictable nature of the job market, investments in these technologies are not slowing down, and recruiting teams are looking to solution providers for additional use cases across the talent acquisition lifecycle, McMullen said. I pointed out.

“As Nucleus Research asserts in this report, the talent acquisition field remains crowded, so recruiting teams can meet current and future recruiting needs,” said Daxtra CEO Terry Baker. Nucleus’ research helps you cut through the noise and understand which technologies are trending and which support long-term success. can be clearly understood.”

Baker continued, “Daxtra’s ranking as an accelerator allows Nucleus to improve the overall ease of use and functionality of its AI-powered capabilities for search and matching, analytics, and candidate engagement; And we recognized our future-proofed market position: speeding up processes to benefit recruiters and candidates today, tomorrow, and in the months and years to come. It confirms Dakstra’s ability to improve the experience.”

To learn more about Daxtra’s inclusion in Nucleus Research’s 2024 Standalone Talent Acquisition Technology Value Matrix, visit https://nucleusresearch.com/research/single/standalone-talent-acquisition-technology-value-matrix-2024 .

About Dakstra

Daxtra specializes in intelligent recruitment automation, AI-powered search and matching, multilingual resume and job analysis in over 40 languages. Built on AI and machine learning, our technology integrates seamlessly with your recruitment tech stack. Headquartered in the UK, Daxtra has been developing innovative recruitment software since 2002 and supports customers around the world through offices in Europe, North America and Asia Pacific.



Source link

Follow on Google News Follow on Flipboard
Share. Facebook Twitter Pinterest LinkedIn Tumblr Email Copy Link
Previous ArticlePakistan launches new nationwide polio vaccination campaign
Next Article ELANCO ANIMAL HEALTH INCORPORATED (NYSE: ELAN) Deadline
Paul E.
  • Website

Related Posts

Chronic absences have not disappeared. Research shows that poor children are most hurt.

June 5, 2025

American Brain Tumor Society’s Metastatic Brain Tumor Collaborative Announces $50,000 Research Grant Opportunity to Fund High-Risk, High-Impact CNS Metastasis Research

October 31, 2024

Massive yard sale in Newtown benefits pancreatic cancer research

October 31, 2024
Leave A Reply Cancel Reply

Latest Posts

Health Canada approves Novartis’ KISQALI® for HR+/HER2- early breast cancer patients at high risk of recurrence

Sheriff, county lawyer seeking mental health funds at Minnesota State Capitol

Chronic absences have not disappeared. Research shows that poor children are most hurt.

Transport Secretary reveals overhaul of aging pneumatic transport systems

Latest Posts

Subscribe to News

Subscribe to our newsletter and never miss our latest news

Subscribe my Newsletter for New Posts & tips Let's stay updated!

Welcome to Subjectional!

At Subjectional, we believe that informed opinions are the foundation of a vibrant society. Our mission is to provide insightful, engaging, and balanced information across a diverse range of topics that matter to you. Whether you’re interested in the latest developments in health, navigating the complexities of politics, staying updated on sports, exploring technological advancements, or advancing your career, we’ve got you covered.

Facebook X (Twitter) Instagram Pinterest YouTube

Subscribe to Updates

Subscribe to our newsletter and never miss our latest news

Subscribe my Newsletter for New Posts & tips Let's stay updated!

Facebook X (Twitter) Instagram Pinterest
  • Home
  • About Us
  • Advertise with Us
  • Contact us
  • DMCA
  • Privacy Policy
  • Terms & Conditions
© 2025 subjectional. Designed by subjectional.

Type above and press Enter to search. Press Esc to cancel.